Form DEFA14A TANDEM DIABETES CARE

Go back to Form DEFA14A TANDEM DIABETES CARE

Tandem Diabetes Care (TNDM) PT Raised to $36 at CFRA

April 11, 2024 4:02 PM EDT

CFRA analyst Kenneth Leon raised the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $36.00 (from $29.00) while maintaining a Hold rating.

The analyst comments "We raise our target price by $7 to $36 applying a wider risk premium and a forward P/S... More